DUBLIN, May 9, 2025 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced presentation of analyses of its previous Phase 3 program evaluating ampreloxetine, an investigational medicine for the treatment of symptomatic neurogenic orthostatic hypotension (nOH) at the International MSA Congress, taking place May 9-11 in Boston, Massachusetts.A subgroup analysis selected as a platform presentation focused on patients with Multiple System Atrophy (MSA ...

Tips to Help Families Stay Safe and Ready During Wildfire Awareness MonthLOS ANGELES, May 9, 2025 /PRNewswire/ -- In recognition of Wildfire Awareness Month, Mercury Insurance is sharing timely, practical guidance to help families prepare for potential evacuations. From building a go-bag to making a communication plan, these simple steps can help you act swiftly and decisively in the face of danger. "Preparing for a wildfire evacuation involves several critical actions, and starting early is one of the best ...

SEOUL, South Korea, May 9, 2025 /PRNewswire/ -- BRING GREEN, the vegan K-beauty skincare brand from CJ Olive Young, South Korea's largest beauty retailer, is launching its Tea Tree Cica sun care line in the U.S. market via Amazon this May. The new products include the Tea Tree Cica Facial Sun Cushion and Tea Tree Cica Sun Cream, both featuring a lightweight formula tailored for sensitive skin. BRING GREEN’s Tea Tree Cica Sun Duo Facial Sun Cushion and Sun Cream for calm, protected skin. BRING GREEN's s ...

Corvus Pharmaceuticals, Inc. CRVS on Thursday released new interim data from the Phase 1 clinical trial evaluating soquelitinib in patients with moderate to severe atopic dermatitis.The data demonstrated a favorable safety and efficacy profile, including earlier and deeper responses in cohort 3 (200 mg twice per day, total daily dose 400 mg) compared to cohorts 1 and 2 (100 mg twice per day and 200 mg once per day, total daily dose 200 mg).Overall, all three cohorts showed significant responses in the soque ...

I ventured into investing in high school in 2011, mainly in REITs, preferred stocks, and high-yield bonds, starting a fascination with markets and the economy that has not faded despite the years. More recently I have been combining long stock positions with covered calls and cash secured puts. I approach investing purely from a fundamental long-term point of view. On Seeking Alpha I mostly cover REITs and financials, with occasional articles on ETFs and other stocks driven by a macro trade idea.Analyst’s D ...

MACOM Technology Solutions Holdings, Inc. (MTSI) reported second-quarter fiscal 2025 earnings of 85 cents per share, which beat the Zacks Consensus Estimate by 1.2%. This company reported earnings of 59 cents per share a year ago.MACOM Technology’s earnings beat the Zacks Consensus Estimate twice in the trailing four quarters while missing the same on the other two occasions, the average surprise being 0.75%.MTSI posted revenues of $235.89 million in the second quarter of fiscal 2025, surpassing the Zacks C ...

Lamar Advertising Company (LAMR) reported first-quarter 2025 adjusted funds from operations (AFFO) per share of $1.60, which outpaced the Zacks Consensus Estimate of $1.54. The figure also compared favorably with the prior-year quarter's tally of $1.54.Results reflect year-over-year growth in the top line. However, higher direct advertising and general and administrative expenses during the quarter acted as a dampener. LAMR has also reaffirmed its full-year 2025 outlook.Quarterly net revenues of $505.4 mill ...

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, has filed a securities class action lawsuit in the United States District Court for the Middle District of Florida against Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NASDAQ: TMCI), and certain of its former and current officers and/or directors (collectively, “Defendants”). The Class Action asserts claims under §§10(b) and 20(a ...

Highlights DraftKings’ Q1 2025 earnings results were impacted by a record-high win rate for high seeds during March Madness, favoring bettors and cutting into the company’s sportsbook margins — although revenue still rose 20% year over year to $1.41 billion. DraftKings is investing in AI and unique betting features, enhancing product offerings and customer experience while positioning itself as a leader in innovation. The company lowered its 2025 guidance due to short-term unfavorable outcomes but em ...

At the end of last month, Berkshire Hills Bancorp (NYSE: BHLB ) reported Q1 2025 results that beat expectations on both the top and bottom line. Non-GAAP earnings of $0.60 were 13% better than anticipated and over 22% better than the same period last year. NetI have been involved in the financial world for over 20 years with experience as an advisor, teacher, and writer. I am a full believer in the free-market system and that financial markets are efficient with most stocks reflecting their real current val ...